Race to Become Conservation's Operating System
Colossal Biosciences
This rivalry is really a contest over who becomes the operating system for high tech conservation. Colossal brings money, in house labs, and spectacle that can pull top scientists and headline projects into one branded pipeline. Revive & Restore brings a long record of working through zoos, universities, and wildlife agencies, which matters when access to animals, tissue samples, permits, and public legitimacy depends on trust built over many years.
-
The competition for specimens is concrete. Revive & Restore centers its work on frozen cell lines, reference genomes, and reproductive tools for endangered species, while Colossal is now building a U.S. endangered species biobank with the Fish and Wildlife Service. The same rare tissue and cell access can support either group’s programs.
-
The competition for donors is also a competition between models. Revive & Restore raises philanthropic support for a distributed research network. Colossal pairs philanthropy with venture capital, a foundation, and large public partnerships, giving it much more firepower but also a stronger incentive to own the public story around de extinction and species recovery.
-
The competition for researchers comes down to where ambitious wildlife biotech work gets done. Colossal funds internal teams and sponsored lab work across genome engineering and reproductive biology. Revive & Restore funds and coordinates outside scientists across projects like passenger pigeon revival, Przewalski's horse cloning, and stem cell tools for conservation.
Going forward, the winner will be the group that turns conservation biotech from isolated moonshots into repeatable field infrastructure. That means owning the specimen pipelines, agency relationships, scientific talent, and public imagination needed to make genetic rescue feel less like an experiment and more like standard wildlife management.